CYDY Company Profile

CYDY Time & Sales

CYDY Recent News

CYDY Filings

CYDY Financials

CYDY Buy Rating

MidnightRider

07/16/2025 11:09:33 AM

indeed it is Kat....I have no choice to (5)

Katangolo

07/16/2025 10:42:30 AM

Gotcha. Sorry I know it was pretty deep (10)

cardamine

07/16/2025 10:18:30 AM

Or in the words of the great Denzel, (3)

KenChowder

07/16/2025 9:37:55 AM

To be honest, to a layperson like (13)

Katangolo

07/16/2025 9:26:47 AM

Hes saying we are onto something (2)

KenChowder

07/16/2025 9:15:42 AM

Good news, Riz. But what is My saying? (2)

Riztheinvestor

07/16/2025 9:00:39 AM

You are brilliant (1)

HouseofCards

07/16/2025 12:39:26 AM

The fiscal year end was May

cardamine

07/16/2025 12:26:38 AM

Looks like that 5-year sample deadline (3)

My69z

07/16/2025 12:05:37 AM

NCT02175680 04-16-2014 HIV Patient

MJS719

07/15/2025 10:34:36 PM

And apparently this group of (6)

Figgs

07/15/2025 10:15:41 PM

I am with you on this one ER! If we (3)

MJS719

07/15/2025 10:11:34 PM

Well, at the very least we know that (12)

My69z

07/15/2025 10:11:15 PM

Page 10 of the trial paper Nov. 19th,

My69z

07/15/2025 10:08:38 PM

12-07-2020 --- NCT02859961 Enrollment (8)

Shelly2626

07/15/2025 7:25:58 PM

Yep Agreed GLTA Longs

MGK_2

07/15/2025 6:51:35 PM

just ignore that last post: when is (3)

MidnightRider

07/15/2025 5:39:32 PM

Are we operating by a Fiscal or

My69z

07/15/2025 3:05:09 PM

Dr. J brkfst news for u: I had my (1)

Evil Rabbit

07/15/2025 3:03:31 PM

I'd take a PR around what Dr. J. had (22)

Mr3Putt

07/15/2025 2:54:19 PM

Imagine news I try man, I try. Getting (9)

My69z

07/15/2025 2:40:19 PM

Imagine news of LL upregulated CD4+ T (3)

My69z

07/15/2025 2:23:44 PM

FDA regulations, reserve samples from (2)

My69z

07/15/2025 9:12:38 AM

Kat...don't know the legal time limit

Katangolo

07/15/2025 9:02:03 AM

I would sure hope so. Thats how I (3)

My69z

07/15/2025 8:11:27 AM

5 in Hiv rolled over in the trial & @ (2)

My69z

07/15/2025 1:02:37 AM

Date: 26-May-2021 Protocol Number: (7)

brentie

07/14/2025 4:16:50 PM

"Our understanding of the genetics (6)

Riztheinvestor

07/14/2025 11:43:44 AM

We have a AI partner with identity (2)

Figgs

07/13/2025 11:04:48 PM

I was trying to put a positive spin on (2)

dfwl28

07/13/2025 7:58:30 PM

https://youtu.be/GIUu239FWMg (8)

sean007

07/13/2025 7:46:15 PM

Here's another mystery...where's the $2 (3)

sean007

07/13/2025 6:31:47 PM

I'm educated on the same level with (3)

Katangolo

07/13/2025 6:20:59 PM

OK, Im picking up the jacket and (7)

Riztheinvestor

07/13/2025 5:22:38 PM

Will AI cut review times? The truth (6)

enemyofpluto

07/13/2025 4:40:59 PM

3500 job cuts (by doge, mush and trump) (17)

ohm20

07/13/2025 4:35:09 PM

Thank you for verifying. Point 2) is an (15)

sean007

07/13/2025 4:27:05 PM

Wouldn't AI help to ramp the speed up (2)

chazzledazzle

07/13/2025 4:18:05 PM

The one problem with this will be (4)

Katangolo

07/13/2025 4:16:13 PM

Wow. Thats big. Thanks again for

ohm20

07/13/2025 4:14:39 PM

Amid the FDA chaos there is a new (8)

ohm20

07/13/2025 4:08:26 PM

The chemo causes indiscriminate DNA (12)

Katangolo

07/13/2025 4:00:52 PM

Thank you for verifying. Point 2) is an (4)

Riztheinvestor

07/13/2025 3:47:43 PM

1. Chemotherapys Broad Damage: (3)

Figgs

07/13/2025 3:45:44 PM

Amid the FDA chaos there is a new (6)

Katangolo

07/13/2025 3:33:19 PM

Awesome. Thank you for that. As a

ohm20

07/13/2025 3:29:55 PM

I think BPG's drug would add little to (6)

Katangolo

07/13/2025 3:28:19 PM

Then we have this New MOA which (1)

Katangolo

07/13/2025 3:26:10 PM

BPG thought that it couldnt hurt and (2)

Katangolo

07/13/2025 3:22:01 PM

Thanks again, Ohm. So does this mean

Newer

Older

Recent Articles

• Snowflake's Mike Gannon Sparks SEC Filing After Influencer Talk
• Livestrong Foundation's Annual Challenge Empowers Cancer Survivors
• Google's Decision to Shift Women Techmakers Program Sparks Controversy
• Podiatry Content Connection Unveils Innovative AI Solutions
• zerohash Europe Gets MiCAR Authorization for Crypto Services
• Tech Titans' Dinner Sparks Fried Chicken Stock Boom
• The Rise of the Silver American Eagle: Why Stackers Are Going All In
• Tenaris Launches $600 Million in Share Buyback for Investors
• Kiyosaki Advocates for Bitcoin and Ethereum Amid Market Uncertainty
• Tenaris Launches $600 Million in Share Buybacks Amid Growth
• Exploring AI Adoption Among Small Businesses Across The U.S.
• Shiba Inu ETF Filing Sparks Significant Token Burn Event
• Investors of Avantor, Inc. Encouraged to Seek Justice Together
• Al Salam Bank Commemorates ASB Capital's Successful Year
• Tom Lee: The Trusted Face of Ethereum in the Finance World
• Elon Musk and Sam Altman: The Roadster Refund Debate
• Navigating Career Transitions: Insights from Industry Experts
• Key Steps for Fortinet, Inc. Investors Ahead of Class Action
• Air Traffic Controllers Face Staffing Crisis Amid Shutdown
• Warren Challenges Trump on Rising Costs Affecting Families
• James Hardie Industries Investors Invited to Join Critical Lawsuit
• Fluor Corporation's Investors Encouraged to Act Now for Justice
• Bitcoin Surges to $100K Amidst Market Challenges and Insights
• Ziegler Successfully Completes $44M Financing for Frasier
• Lowe's Contributes $1 Million for Hurricane Recovery in Jamaica
• Celebrate Dodgers' Triumph with New Era's 2025 Collection
• Richmond Terrace Capital Launches New €1.5 Billion Investment Fund
• Ameripath USA Collaborates with Recovery Resolutions to Support Recovery Housing
• Sequoia Capital Launches $950M Fund to Fuel AI Innovators
• Virginia Veterans Celebrate with Free Book Vouchers for Stories
• Innovative Advancements of Poain BlockEnergy in Global DeFi Market
• Investors of aTyr Pharma Should Secure Legal Help Now
• Bahrain Premieres Revolutionary Rooftop Solar Power Initiative
• Deqing's Pearl Mussel Award: A Mark of Agricultural Heritage
• Buck Sexton Unveils the Dawn of America’s Next Wealth Era
• Navigating the Promising Journey of Mutuum Finance and MUTM
• Belite Bio's Conditional Marketing Authorization Success for Tinlarebant
• Top Large-Cap Movers: Teradyne, Wayfair, and More Insights
• Top Stock Insights: Palantir's Surge and Pfizer's Struggles
• The Last Messages of Charlie Kirk Revealing His Fears
• Significant Stock Declines: Fiserv, eBay, and Garmin Under Pressure
• Major Moves in Tech: Earnings Reports & Market Trends Ahead
• Ford Faces Major Recall Challenges But Sees Opportunities Ahead
• Discover the Hidden Gems: Stocks Gaining Investor Interest
• OncoHost Showcases Innovative Insights in NSCLC Proteomics
• Mutuum Finance Gears Up for Exciting V1 Launch with $18M Raised
• Apple's Impressive Earnings, Bold Future Predictions Unveiled
• Fangzhou's Innovative AI Solutions Transform Chronic Care Management
• Fangzhou Innovates Chronic Disease Management with AI Solutions
• CoorsTek Bioceramics Triumphs in Legal Right to Market Hip Components